LIFEWARD LTD (LFWD)

IL0011331076 - Common Stock

1.98  -0.23 (-10.41%)

After market: 1.9881 +0.01 (+0.41%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LFWD. LFWD was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of LFWD is average, but there are quite some concerns on its profitability. While showing a medium growth rate, LFWD is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LFWD has reported negative net income.
LFWD had a negative operating cash flow in the past year.
In the past 5 years LFWD always reported negative net income.
In the past 5 years LFWD always reported negative operating cash flow.

1.2 Ratios

LFWD has a worse Return On Assets (-42.17%) than 62.37% of its industry peers.
LFWD's Return On Equity of -56.95% is in line compared to the rest of the industry. LFWD outperforms 47.31% of its industry peers.
Industry RankSector Rank
ROA -42.17%
ROE -56.95%
ROIC N/A
ROA(3y)-24.94%
ROA(5y)-36.97%
ROE(3y)-30.18%
ROE(5y)-58.88%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 35.26%, LFWD is doing worse than 70.43% of the companies in the same industry.
LFWD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LFWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.6%
GM growth 5Y-5.73%

More info and screens

6

2. Health

2.1 Basic Checks

LFWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
LFWD has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for LFWD has been increased compared to 5 years ago.
There is no outstanding debt for LFWD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -7.25, we must say that LFWD is in the distress zone and has some risk of bankruptcy.
LFWD's Altman-Z score of -7.25 is on the low side compared to the rest of the industry. LFWD is outperformed by 75.27% of its industry peers.
LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.25
ROIC/WACCN/A
WACC9.36%

2.3 Liquidity

A Current Ratio of 2.65 indicates that LFWD has no problem at all paying its short term obligations.
LFWD has a Current ratio (2.65) which is comparable to the rest of the industry.
A Quick Ratio of 1.90 indicates that LFWD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.90, LFWD is in line with its industry, outperforming 46.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 1.9

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.86% over the past year.
Looking at the last year, LFWD shows a very strong growth in Revenue. The Revenue has grown by 173.28%.
LFWD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.18% yearly.
EPS 1Y (TTM)3.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)173.28%
Revenue growth 3Y46.65%
Revenue growth 5Y16.18%
Sales Q2Q%39.18%

3.2 Future

LFWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.55% yearly.
The Revenue is expected to grow by 60.99% on average over the next years. This is a very strong growth
EPS Next Y33.9%
EPS Next 2Y30.1%
EPS Next 3Y27.69%
EPS Next 5Y25.55%
Revenue Next Year78.92%
Revenue Next 2Y62.53%
Revenue Next 3Y74.13%
Revenue Next 5Y60.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LFWD. In the last year negative earnings were reported.
Also next year LFWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LFWD's earnings are expected to grow with 27.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.1%
EPS Next 3Y27.69%

More info and screens

0

5. Dividend

5.1 Amount

LFWD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFEWARD LTD

NASDAQ:LFWD (1/8/2025, 8:13:41 PM)

After market: 1.9881 +0.01 (+0.41%)

1.98

-0.23 (-10.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners21.65%
Inst Owner ChangeN/A
Ins Owners2.77%
Ins Owner Change49.08%
Market Cap17.44M
Analysts82.5
Price Target9.69 (389.39%)
Short Float %2.15%
Short Ratio2.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.97%
Min EPS beat(2)-8.93%
Max EPS beat(2)10.87%
EPS beat(4)1
Avg EPS beat(4)-6.94%
Min EPS beat(4)-27.45%
Max EPS beat(4)10.87%
EPS beat(8)2
Avg EPS beat(8)-8.44%
EPS beat(12)2
Avg EPS beat(12)-22.54%
EPS beat(16)4
Avg EPS beat(16)-18.31%
Revenue beat(2)0
Avg Revenue beat(2)-15.04%
Min Revenue beat(2)-28.9%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-10.83%
Min Revenue beat(4)-28.9%
Max Revenue beat(4)-1.18%
Revenue beat(8)2
Avg Revenue beat(8)-10.02%
Revenue beat(12)2
Avg Revenue beat(12)-21.48%
Revenue beat(16)5
Avg Revenue beat(16)-14.25%
PT rev (1m)0%
PT rev (3m)-11.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-16.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.7
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-2.49
EYN/A
EPS(NY)-0.88
Fwd EYN/A
FCF(TTM)-2.53
FCFYN/A
OCF(TTM)-2.52
OCFYN/A
SpS2.84
BVpS3.85
TBVpS1.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.17%
ROE -56.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.26%
FCFM N/A
ROA(3y)-24.94%
ROA(5y)-36.97%
ROE(3y)-30.18%
ROE(5y)-58.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.6%
GM growth 5Y-5.73%
F-Score3
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.07%
Cap/Sales 0.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.65
Quick Ratio 1.9
Altman-Z -7.25
F-Score3
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)11.48%
Cap/Depr(5y)13.38%
Cap/Sales(3y)0.61%
Cap/Sales(5y)0.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y33.9%
EPS Next 2Y30.1%
EPS Next 3Y27.69%
EPS Next 5Y25.55%
Revenue 1Y (TTM)173.28%
Revenue growth 3Y46.65%
Revenue growth 5Y16.18%
Sales Q2Q%39.18%
Revenue Next Year78.92%
Revenue Next 2Y62.53%
Revenue Next 3Y74.13%
Revenue Next 5Y60.99%
EBIT growth 1Y9.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.39%
OCF growth 3YN/A
OCF growth 5YN/A